Volitionrx (VNRX) Payables (2011 - 2025)

Volitionrx (VNRX) has 11 years of Payables data on file, last reported at $5.3 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 92.94% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $5.3 million (up 92.94% YoY), and the FY2025 full-year result was $5.3 million, up 92.94% from the prior year.
• Payables for Q4 2025 stood at $5.3 million, up from $4.6 million in the prior quarter.
• Across five years, Payables topped out at $5.3 million in Q4 2025 and bottomed at $1.1 million in Q2 2021.
• The 5-year median for Payables is $3.0 million (2023), against an average of $2.9 million.
• The widest annual swing landed in 2022, when Payables jumped 140.24%; it then decreased 24.8% in 2025.
• A 5-year view of Payables shows it stood at $1.5 million in 2021, then jumped by 97.28% to $3.0 million in 2022, then gained by 5.53% to $3.2 million in 2023, then slipped by 13.86% to $2.8 million in 2024, then surged by 92.94% to $5.3 million in 2025.
• The last three Payables figures came in at $5.3 million (Q4 2025), $4.6 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.

Peer Comparison